Introduction
============

The ends of linear chromosomes are formed by a special heterochromatic structure, known as telomeres, which protect chromosome ends from degradation and repair activities and, therefore, are essential to ensure chromosome stability ([@bib59]; [@bib12]; [@bib28]; [@bib14]; [@bib56]; [@bib9]; [@bib16]; [@bib4]; [@bib46]). Mammalian telomeres are formed by tandem repeats of the TTAGGG sequence bound by a specialized six-protein complex, known as shelterin, which has roles in telomere capping and the regulation of telomerase activity at chromosome ends. The shelterin complex is composed of six core proteins, TRF1 and TRF2 (the telomeric repeat binding factors 1 and 2, respectively), the TIN2 (TRF1-interacting protein 2), POT1 (protection of telomeres protein 1), TPP1, and RAP1 ([@bib54]; [@bib16]; [@bib46]; [@bib35], [@bib36]). Complete abrogation of most these components results in early embryonic lethality in mice with the exception of Rap1, which is also dispensable for telomere protection ([@bib29]; [@bib11]; [@bib9]; [@bib26]; [@bib31]; [@bib68]; [@bib30]; [@bib53]; [@bib36]). When telomeres become critically short or unprotected because of shelterin deficiencies, they trigger an ataxia telangiectasia mutated (ATM)-- or ataxia telangiectasia and Rad3 related (ATR)--dependent DNA damage response (DDR) at chromosome ends, which are then recognized as double-strand breaks (DSBs; [@bib17]; [@bib35]; [@bib57]).

Mammalian DSBs are repaired by homologous recombination (HR) or nonhomologous end joining (NHEJ). HR initiates error-free repair between homologous repeated sequences. It requires the MRN complex to tether DNA ends and CtIP to generate the 3′ single-stranded DNA (ssDNA) substrate necessary for HR ([@bib51]; [@bib39]; [@bib66]). NHEJ is an error-prone repair that also requires the MRN complex and is composed of two pathways, the classical NHEJ (C-NHEJ) and the alternative NHEJ (A-NHEJ; [@bib13]; [@bib45]; [@bib55]; [@bib70]; [@bib32]; [@bib33]). The C-NHEJ requires Ku70/86 and the DNA ligase IV (Lig4)--XRCC4 complex. The A-NHEJ fuses DNA ends that display microhomology and is dependent on PARP1 (poly (ADP-ribose) polymerase-1) and the XRCC1--DNA ligase III (Lig3) complex ([@bib1]; [@bib62]; [@bib24]). As in the case of DSBs, uncapped telomeres are repaired by activation of the HR and NHEJ pathways, leading to telomere length changes and end to end fusions, respectively ([@bib17]; [@bib18]). End to end fusions can arise from the activation of either the C-NHEJ or the A-NHEJ pathways, depending on how telomeres are rendered dysfunctional ([@bib48]). For example, fusions arising upon TRF2 depletion are mediated by the C-NHEJ, whereas fusions induced by TPP1-POT1 depletion are mediated by the A-NHEJ pathway ([@bib48]).

53BP1 is a C-NHEJ component and an ATM target that accumulates at DSBs and at uncapped telomeres ([@bib49]; [@bib23]; [@bib61]; [@bib56]). The interaction of 53BP1 with chromatin involves the binding of its tudor domains to H4K20me2 and an MDC1-dependent interaction with γ-H2AX ([@bib63]; [@bib3]; [@bib5]). Although 53BP1 is dispensable for DNA damage signaling, the NHEJ of DSBs is severely affected by 53BP1 deficiency ([@bib34]; [@bib65]). Deletion of 53BP1 in cells with severe telomere uncapping as a result of TRF2 deficiency established that NHEJ of dysfunctional telomeres is strongly dependent on the binding of 53BP1 to damaged chromosome ends ([@bib19]; [@bib48]). Binding of 53BP1 close to DNA breaks impacts the dynamic behavior of the local chromatin and facilitates the NHEJ repair reactions that involve distant sites ([@bib19]). Depletion of 53BP1 has been recently shown to restore HR defects in *BRCA1*-deficient cells and to abrogate the ATM-dependent checkpoint response and G2 cell cycle arrest triggered by the accumulation of DNA breaks ([@bib6]; [@bib7]). In particular, removal of 53BP1 from DSBs is crucial for the ATM-dependent resection to produce recombinogenic ssDNA that precedes the homology-directed repair of the break ([@bib7]). Thus, the current notion is that removal of end-joining proteins, such as 53BP1, from breaks enables resection by CtIP, RPA loading onto ssDNA regions, and further RPA displacement by RAD51 promoting strand invasion at the homologous region of the sister chromatid ([@bib7]).

*TRF1* deletion in mice produces embryonic lethality at the blastocyst stage, without apparent defects in telomere length or telomere capping ([@bib29]). The recent development of conditional *TRF1* alleles demonstrated that *TRF1* deletion leads to rapid induction of senescence in differentiated cells, which is concomitant with the formation of telomeric γ-H2AX foci and phosphorylation of ATM and the ATM/ATR downstream checkpoint kinases CHK1 and CHK2 ([@bib37]; [@bib52]). Abrogation of the p53 and retinoblastoma (Rb) pathways in these cells bypasses senescence but leads to chromosome instability, including sister chromatid fusions, chromosome concatenation, and occurrence of multitelomeric signals (MTSs) associated with replication fork stalling at telomeres ([@bib37]; [@bib52]) in the absence of changes in telomere length ([@bib37]). Mice conditionally deleted for *TRF1* in stratified epithelia, *TRF1^Δ/Δ^ K5-cre* mice, show perinatal lethality and severe skin morphogenesis defects, which are concomitant with increased telomere damage, activation of the p53--p21 and p16 pathways, and cell cycle arrest in vivo ([@bib37]). Interestingly, stratified epithelia from *TRF1*-deficient mice also develop preneoplastic lesions (dysplasia and hyperkeratosis), which progress to invasive and genetically unstable squamous cell carcinomas in combination with p53 deficiency ([@bib37]). In turn, p53 deficiency rescues hair follicle stem cell defects, skin hyperpigmentation, and mouse survival, indicating that proliferative defects associated with *TRF1* abrogation are mediated by p53.

Here, we set out to dissect the role of 53BP1 at telomeres rendered dysfunctional by TRF1 deficiency. Given that *TRF1*-deleted cells showed abundant end to end fusions and that 53BP1 is required for the C-NHEJ--mediated ligation of DNA ends, we set out to address the contributions of aberrant chromosome rearrangements to the deleterious effects of *TRF1* deletion in vivo. Chromosome-type end to end fusions were significantly rescued in TRF1- and 53BP1-deficient mouse embryonic fibroblasts (MEFs), but this was accompanied by an increase in HR at telomeres. *TRF1^Δ/Δ^* *53BP1^−/−^* MEFs showed a stronger CHK1 activation and increased RPA recruitment to telomeres, suggesting presence of recombinogenic ssDNA at telomeres and hyperactivation of the ATR-dependent DDR. Indeed, in marked contrast to the complete rescue of phenotypes induced by 53BP1 deficiency in the context of the *BRCA1* knockout mice, *TRF1^Δ/Δ^ K5-Cre 53BP1^−/−^* mice showed aggravated phenotypes compared with the TRF1-deficient controls. The *TRF1^Δ/Δ^ K5-Cre 53BP1^−/−^* mice showed earlier onset of telomeric DNA damage and of ATR-mediated DDR activation than the *TRF1^Δ/Δ^ K5-Cre 53BP1^+/+^* littermates during embryonic development. Keratinocytes derived from *TRF1^Δ/Δ^ K5-Cre 53BP1^−/−^* newborns also showed a stronger G2 arrest and increased polyploidy compared with *TRF1^Δ/Δ^ K5-Cre 53BP1^+/+^* keratinocytes. These results are the first to reveal that the in vivo loss of a telomeric protein in combination with a DNA repair component enhances early demise.

Results
=======

53BP1 deficiency does not rescue growth defects of *TRF1*-deleted MEFs
----------------------------------------------------------------------

To study the impact of 53BP1 deficiency in cells deleted for *TRF1*, we generated MEFs of the *TRF1^+/+^* *53BP1^+/+^*,*TRF1^+/+^* *53BP1^−/−^*,*TRF1^flox/flox^* *53BP1^+/+^*, and *TRF1^flox/flox^* *53BP1^−/−^* genotypes by crossing *53BP1^−/−^* ([@bib64]) with *TRF1^flox/flox^* mice ([@bib37]). To prevent induction of p53/Rb-dependent senescence as a consequence of *TRF1* deletion ([@bib37]), we first immortalized MEFs with SV40 large T antigen (LT), which abrogates the p53 and Rb pathways, and then transduced them with a pBabe-Cre retrovirus to generate the *TRF1^Δ^* allele ([Fig. 1 A](#fig1){ref-type="fig"}). *TRF1^Δ/Δ^ 53BP1^+/+^* and *TRF1^Δ/Δ^ 53BP1^−/−^* Cre-LT MEFs grew at similar rates, and both failed to proliferate further than two-cell divisions ([Fig. 1 B](#fig1){ref-type="fig"}). As expected, no differences in growth rates were detected between wild-type and *53BP1^−/−^* cells. No significant differences were detected in the cell cycle profile between *TRF1^Δ/Δ^ 53BP1^+/+^* and *TRF1^Δ/Δ^ 53BP1^−/−^* Cre-LT MEFs ([Fig. S1](http://www.jcb.org/cgi/content/full/jcb.201110124/DC1){#supp1}).

![**MEFs doubly deficient for TRF1 and 53BP1 show decreased chromosome-type end to end fusions but increased telomere recombination.** (A) *TRF1* deletion in *TRF1^flox/flox^* SV40 LT-immortalized MEFs upon retroviral infection with Cre recombinase was confirmed by PCR amplification of *TRF1* alleles. The black line indicates that intervening lanes have been spliced out. (B) Growth curves of the indicated independent MEF lines. *n*, number of independent MEF cultures of the indicated genotypes. (C) Representative images of metaphase spreads of the indicated genotypes. Green arrowheads indicate MTS, white arrowheads indicate sister chromatid fusions, red arrowheads indicate dicentric chromosomes, the gold arrowhead indicates multicentric chromosomes, and blue arrowheads indicate T-SCE (yellow signals). (D) Frequency of the indicated aberrations in metaphase spreads of the indicated genotypes. *n*, independent MEFs used per genotype. From 6 to 11 metaphases were taken per independent MEF, making a total of ≥20 metaphases analyzed per genotype. Error bars indicate standard deviation. Statistical differences were calculated using the Student's *t* test, and p-values are indicated. Mr, molecular marker. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001.](JCB_201110124_Fig1){#fig1}

53BP1 deficiency rescues chromosome-type end to end fusions but results in increased telomere recombination associated with TRF1 abrogation
-------------------------------------------------------------------------------------------------------------------------------------------

To evaluate the contribution of 53BP1 in the generation of chromosomal aberrations arising upon TRF1 deletion, we performed metaphase chromosome orientation FISH (CO-FISH) on *TRF1^Δ/Δ^ 53BP1^+/+^* and *TRF1^Δ/Δ^ 53BP1^−/−^* Cre-LT MEFs ([Fig. 1 C](#fig1){ref-type="fig"}), which allows the visualization of both the leading and lagging telomere strands and can be used to determine the frequency of telomeric sister chromatid exchange (T-SCE) events (see Materials and methods). TRF1 deficiency has been previously shown to lead to telomeric DNA breakage associated with stalled replication forks, which results in chromosome ends with more than one telomere signal, the so-called MTS ([@bib37]; [@bib52]). In agreement with this, *TRF1*-deleted MEFs showed a very high incidence of MTS (\>20% of chromosomes; [Fig. 2 D](#fig2){ref-type="fig"}). Simultaneous deficiency in 53BP1, however, did not significantly affect MTS frequency as compared with *TRF1^Δ/Δ^* controls, indicating that 53BP1 does not impact telomere fragility associated with TRF1 depletion. Interestingly, *TRF1^Δ/Δ^ 53BP1^−/−^* cells showed significantly less chromosome-type fusions, dicentric and multicentric chromosomes, compared with *TRF1^Δ/Δ^ 53BP1^+/+^* MEFs ([Fig. 1 D](#fig1){ref-type="fig"}). These findings are in agreement with a role for 53BP1 in the repair of dysfunctional telomeres through the C-NHEJ pathway. Nevertheless, the fact that chromosome fusions are still observed in the absence of 53BP1 indicates that end to end fusions associated with TRF1 deficiency can also be generated by the A-NHEJ pathway, although to a much lesser extent. The frequency of sister chromatid-type fusions, although significantly lower in MEFs lacking both TRF1 and 53BP1 compared with MEFs lacking only TRF1, was remarkably high, reaching values \>10% of total chromosomes ([Fig. 1 D](#fig1){ref-type="fig"}). Therefore, 53BP1 deficiency merely suppresses sister chromatid-type fusion events. These results indicate that chromatid-type fusion events are either also mediated by the A-NHEJ pathway and/or originate from sister chromatid bridges at fragile sites. The frequency of chromosome breaks and fragments was not affected by 53BP1 deficiency ([Fig. 1 D](#fig1){ref-type="fig"}).

![**53BP1 deficiency in *TRF1^Δ/Δ^*-immortalized MEFs leads to stronger CHK1 activation.** (A) Percentage of nuclei exhibiting ≥10 γ-H2AX foci and pannuclear γ-H2AX staining in Cre-infected LT-immortalized MEFs 6 d after selection. Error bars indicate standard deviation. (B) Number of TIF per nuclei determined by immunofluorescence detection of γ-H2AX and RAP1. The number of cells analyzed in each case is indicated. Statistical differences were calculated using the Student's *t* test, and p-values are indicated. Red lines correspond to mean values. (C) Representative combined images of γ-H2AX foci, RAP1, and DAPI of the indicated genotypes. Insets represent larger magnification of the squared areas, and TIF are visualized as yellow spots. (D) Western blot detection of DDR factors in Cre-infected LT-immortalized MEFs 4 d after selection of the indicated genotypes. RAD21 and actin were used as loading controls. The black line indicates that intervening lanes have been spliced out. ACT, actin.](JCB_201110124_Fig2){#fig2}

Strikingly, 53BP1 deficiency increased HR events between sister chromatids (T-SCE) by fivefold in *TRF1^Δ/Δ^ 53BP1^−/−^* compared with *TRF1^Δ/Δ^ 53BP1^+/+^* MEFs ([Fig. 1 D](#fig1){ref-type="fig"}). These results indicate that, in the absence of 53BP1, repair of dysfunctional telomeres caused by TRF1 deficiency is unbalanced from NHEJ toward HR. Finally, we did not observe any differences in the length of the G-strand overhang between *TRF1^Δ/Δ^ 53BP1^+/+^* and *TRF1^Δ/Δ^ 53BP1^−/−^* MEFs as determined by terminal restriction fragment (TRF) analysis ([Fig. S2, A--C](http://www.jcb.org/cgi/content/full/jcb.201110124/DC1){#supp2}).

53BP1 deficiency in *TRF1*-null MEFs leads to stronger CHK1 activation and telomeric RPA foci
---------------------------------------------------------------------------------------------

A switch from the NHEJ to the HR pathway as a consequence of 53BP1 abrogation in TRF1-deficient MEFs may also affect the DDR. To explore this, we first evaluated the impact of 53BP1 deletion on the presence of uncapped telomeres associated with TRF1 deficiency as determined by γ-H2AX foci ([@bib41]; [@bib14]; [@bib56]; [@bib37]; [@bib52]). 53BP1 deficiency did not affect the number of cells showing \>10 γH2AX foci but had an impact on the number of cells showing γ-H2AX pannuclear staining ([Fig. 2 A](#fig2){ref-type="fig"}). Similarly, we did not see an impact of 53BP1 deficiency in the number of γ-H2AX foci colocalizing to telomeres, the so-called telomeric-induced damage foci (TIF; [Fig. 2, B and C](#fig2){ref-type="fig"}). These results indicate that the massive uncapping of telomeres that occurs as a consequence of TRF1 deletion is not affected by 53BP1 deficiency in MEFs.

TIF induction after *TRF1* deletion is accompanied by phosphorylation of ATM and the ATM/ATR downstream checkpoint kinases CHK2 and CHK1 ([@bib37]; [@bib52]). To address the impact of 53BP1 deficiency on DDR activation as a consequence of TRF1 deletion, we performed Western blotting of different components of the ATM and ATR axis ([Fig. 2, D and E](#fig2){ref-type="fig"}). No differences in the ATM signaling pathway were observed between *TRF1^Δ/Δ^ 53BP1^−/−^* and *TRF1^Δ/Δ^ 53BP1^+/+^* MEFs, as seen by similar levels of phospho-KAP1 and phospho-CHK2 in both settings ([Fig. 2 D](#fig2){ref-type="fig"}). In contrast, *TRF1^Δ/Δ^ 53BP1^−/−^* cells showed a much stronger signal of the ATR downstream checkpoint kinase phospho-CHK1 and higher levels of phopho-RPA32 compared with *TRF1^Δ/Δ^ 53BP1^+/+^* cells ([Fig. 2 D](#fig2){ref-type="fig"} and [Fig. S3, A and B](http://www.jcb.org/cgi/content/full/jcb.201110124/DC1){#supp3}). These results are consistent with previous findings showing that abrogation of 53BP1 in *BRCA1^−/−^* cells affects the levels of phosphorylated RPA upon DNA damage but does not affect the ATM--CHK2--p53 signaling pathway ([@bib8]; [@bib7]). Increased levels of phosphorylated RPA could indicate the presence of ssDNA overhangs at telomeres resulting from DSB resection before their repair by HR ([@bib27]; [@bib51]; [@bib40]). Furthermore, RPA bound to ssDNA is required for the recruitment of ATR to sites of DNA damage and for ATR-mediated CHK1 activation for checkpoint signaling ([@bib71]). To address whether RPA was specifically increased at TRF1-depleted telomeres in the absence of 53BP1, we performed double immunofluorescence with RPA and the telomeric protein RAP1 ([Fig. 3, A--D](#fig3){ref-type="fig"}). The number of cells containing RPA foci (\>10 foci per cell) was fivefold higher in *TRF1^Δ/Δ^ 53BP1^−/−^* compared with *TRF1^Δ/Δ^ 53BP^+/+^* MEFs ([Fig. 3, A and B](#fig3){ref-type="fig"}). Moreover, these foci were significantly increased at telomeres in *TRF1^Δ/Δ^ 53BP1^−/−^* compared with *TRF1^Δ/Δ^ 53BP^+/+^* MEFs ([Fig. 3, C and D](#fig3){ref-type="fig"}), suggesting the presence of ssDNA at telomeric regions and consistent with the observed increase in telomeric recombination frequencies.

![**53BP1 deficiency in *TRF1^Δ/Δ^*-immortalized MEFs leads to increased RPA foci at telomeres.** (A) The percentage of nuclei exhibiting ≥10 RPA foci determined in Cre-infected LT-immortalized MEFs 6 d after selection. Error bars indicate standard deviation. (B) Representative immunofluorescence images of RPA staining of the indicated genotypes. (C) Number of telomeric RPA foci (TIF) per nuclei determined by immunofluorescence detection of RPA and RAP1. Two to three independent MEF lines were assayed per genotype, and the total number of cells analyzed in each case is indicated. Statistical differences were calculated using the Student's *t* test, and p-values are indicated. Red lines correspond to mean values. (D) Representative combined images of RPA foci, RAP1, and DAPI of the indicated genotypes. RPA and RAP1 colocalization events are indicated by arrowheads.](JCB_201110124_Fig3){#fig3}

To confirm telomeric ssDNA, we performed a BrdU staining under nondenaturing conditions. A higher number of cells presenting \>10 BrdU foci was detected in MEFS lacking 53BP1 or TRF1 as compared with wild-type cells, and this number was further increased in cells lacking both 53BP1 and TRF1 ([Fig. 4 A](#fig4){ref-type="fig"}). As the positive control, BrdU staining was increased in γ-irradiated cells as compared with nonirradiated cells ([Fig. 4 B](#fig4){ref-type="fig"}). We observed an increased colocalization of telomeres detected by RAP1 staining with BrdU-visualized ssDNA in *TRF1^Δ/Δ^ 53BP1^−/−^* cells, strongly supporting the presence of ssDNA at telomeres ([Fig. 4, C and D](#fig4){ref-type="fig"}). In summary, these results suggest that 53BP1 deficiency in TRF1-deleted cells results in a switch from the NHEJ to the HR repair mode, which is accompanied by accumulation of ssDNA at telomeres and a hyperactivation of the ATR signaling pathway, including higher levels of CHK1 and phosphorylated RPA.

![**53BP1 deficiency in *TRF1^Δ/Δ^* MEFs results in increased telomeric ssDNA.** (A) The percentage of nuclei exhibiting ≥10 BrdU foci determined in Cre-infected LT-immortalized MEFs 4 d after selection. Error bars indicate standard deviation. (B) Representative immunofluorescence images of BrdU staining of wild-type cells nonirradiated and after 30 Gy treatment of ionizing radiation. As a positive control for ssDNA-BrdU staining, all the MEF lines used for this study were irradiated (30 Gy) and incubated for 90 min to let DNA resection to proceed. (C) Number of telomeric ssDNA foci per nuclei determined by immunofluorescence detection of BrdU and RAP1. Two independent MEF lines were assayed per genotype, and the total number of cells analyzed in each case is indicated. Statistical differences were calculated using the Student's *t* test, and p-values are indicated. Red lines correspond to mean values. (D) Representative combined images of BrdU foci, RAP1, and DAPI of the indicated genotypes. BrdU and RAP1 colocalization events are indicated by arrowheads.](JCB_201110124_Fig4){#fig4}

Aggravation of TRF1 loss--mediated in vivo pathologies by 53BP1 deficiency
--------------------------------------------------------------------------

The impact of activation of the ATR versus the ATM pathway in the context of the organism is dramatically different. Although deficiencies in components of the ATM pathway do not lead to embryonic lethality in mice, mice deleted for the components of the ATR pathway are embryonically lethal, most likely reflecting an essential role of the HR pathway in mammals ([@bib21]; [@bib15]). The results described here suggest that 53BP1 is a key component in the balance between these two modes of repair, favoring the NHEJ pathway over the HR pathway. To study the in vivo impact of 53BP1 abrogation in the context of *TRF1*-deficient mice, we crossed conditional *TRF1^flox/+^ K5-Cre* ([@bib37]) with *TRF1^+/+^ 53BP1^−/−^* mice ([@bib64]) to obtain *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* mice. Doubly deficient *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* mice were born at the expected Mendelian ratios ([Table 1](#tbl1){ref-type="table"}), but none survived past the first day postpartum (P1) in contrast to single-mutant *TRF1^Δ/Δ^* *K5-Cre* mice, in which 8% of the newborns reached day 3 postpartum (P3; [@bib37]). These results indicate that abrogation of 53BP1 enhances early demise associated with TRF1 deficiency. At the macroscopic level, the skin of *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* newborns showed severe epithelial necrosis, resulting in ulcers and hemorrhages, which were not observed in the *53BP1^+/+^* littermates ([Fig. 5 A](#fig5){ref-type="fig"}). *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* mice also showed significantly lower weight at birth than the *TRF1^Δ/Δ^* *K5-Cre* newborns ([Fig. 5 B](#fig5){ref-type="fig"}). Histopathological analysis of the different stratified epithelia in the organism revealed that 100% of double knockout mice present a severe pattern of epithelial atrophy, whereas 75% of the single*TRF1*-deleted skin present a moderate pattern ([Fig. 5 C](#fig5){ref-type="fig"} and [Fig. S4](http://www.jcb.org/cgi/content/full/jcb.201110124/DC1){#supp4}).

###### 

Offspring from *TRF1^flox/flox^ 53BP1^−/−^* and *TRF1^flox/+^ K5-Cre^+/T^ 53BP1^+/−^* and *TRF1^flox/flox^ 53BP1^−/−^* and *TRF1^flox/+^ K5-Cre^+/T^ 53BP1^−/−^* mouse intercrosses

  Crosses                                                                  Total pups   Genotype                                                                                Pups (expected), p-value
  ------------------------------------------------------------------------ ------------ --------------------------------------------------------------------------------------- ----------------------------------------
  *TRF1^flox/flox^ 53BP1^−/−^* and *TRF1^flox/+^ K5-Cre^+/T^ 53BP1^+/−^*   131          *TRF1^flox/flox^ K5-Cre^+/T^ 53BP1^+/−^* and *TRF1^flox/flox^ K5-Cre^+/T^ 53BP1^−/−^*   12 (16), P = 0.4 and 14 (16), P = 0.85
  *TRF1^flox/flox^ 53BP1^−/−^* and *TRF1^flox/+^ K5-Cre^+/T^ 53BP1^−/−^*   67           *TRF1^flox/flox^ K5-Cre^+/T^ 53BP1^−/−^* and *TRF1^flox/flox^ 53BP1^−/−^*               10 (17), P = 0.2 and14 (17), P = 0.7

![**In vivo deleterious genetic interactions between TRF1 and 53BP1.** (A) Representative images of newborn mice of the indicated genotype at birth (P1). (right) Images of two independent *TRF1^Δ/Δ^ K5-Cre 53BP1^−/−^* mice (P1). Arrows indicate areas of epithelial necrosis, ulcers, and hemorrhages. Note the smaller size and more aggravated phenotype of the *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* mice compared with an age-matched *TRF1^Δ/Δ^* *K5-Cre* mouse. (B) Mean weight at birth of the indicated genotypes. Error bars represent standard errors, and the number of mice is indicated in each case. Statistical differences were calculated using the Student's *t* test, and p-values are indicated. (C) Quantification of histopathological findings at birth in different stratified epithelia of the indicated genotypes. Severe pattern refers to a high-grade dysplasia in the skin, tongue, palate, esophagus, nonglandular stomach, nails, and urinary bladder, with marked cytological atypia with disturbed polarity of cells, irregular epithelia stratification, loss of nuclear polarity, prominent nucleoli, and nuclear polymorphism. All tissues present focal hyperplasia and hyperkeratosis. The back skin shows epithelial necrosis and complete absence of hair follicles. Moderate pattern is characterized by a lower grade of dysplasia in skin, tongue, nonglandular stomach, and esophagus, with cells larger than normal, often with irregular stratification, enlarged nuclei, and in some cases, loss of nuclear polarity. The back skin shows primordial hair follicles, and the nails are unaffected. The number of mice analyzed in each case is indicated. Statistical differences are calculated using the χ^2^ test, and p-values are indicated. (D and E) Representative images of back skin sections stained for p63, Sox9, cytokeratin 10, cytokeratin 14 (D), and γ-H2AX (E) at birth of mice from the indicated genotypes. (E, right) Larger magnifications in which different γ-H2AX staining patterns are shown. Note that, in the *TRF1^Δ/Δ^* *K5-Cre*, the γ-H2AX--positive cells display a foci staining in contrast to *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* epidermal γ-H2AX--positive cells that present a pannuclear staining. Note the absence of p63 and Sox9 expression in *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* skin.](JCB_201110124_Fig5){#fig5}

Aggravation of skin phenotypes in *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* newborns with respect to *TRF1^Δ/Δ^* *K5-Cre* newborns was further confirmed by various markers of skin morphogenesis. In particular, *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* skin showed almost complete absence of p63-positive cells, a marker of the basal cell layer, and no staining for SOX9, a marker for epidermal stem cells ([Fig. 5 D](#fig5){ref-type="fig"}). Staining with the differentiation markers cytokeratins K10 and K14 also showed an aggravation of the skin phenotypes associated with single TRF1 deficiency, such as a marked reduction in the cellularity of the suprabasal skin layer as well as the complete absence of primitive hair follicles ([Fig. 5 D](#fig5){ref-type="fig"}).

*TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* mice show earlier onset of DNA damage and of DDR activation
-------------------------------------------------------------------------------------------

To address whether the aggravation of the skin phenotypes produced by 53BP1 deficiency was associated with increased DNA damage at birth, we first determined presence of γ-H2AX in newborn skin. As expected, γ-H2AX--positive cells were completely absent from TRF1 wild-type newborn skin independently of the 53BP1 status. In contrast, 100% of the skin basal layer cells were positive for γ-H2AX in both *TRF1^Δ/Δ^* and *TRF1^Δ/Δ^ 53BP1^−/−^* newborns ([Fig. 5 E](#fig5){ref-type="fig"}). Strikingly, *TRF1^Δ/Δ^ 53BP1^−/−^* skin cells showed a different γ-H2AX staining pattern compared with *TRF1^Δ/Δ^* *K5-Cre* skin. Although *TRF1^Δ/Δ^ 53BP1^+/+^* cells showed a spotted pattern of γ-H2AX foci, characteristic of DSBs and uncapped telomeres, *TRF1^Δ/Δ^ 53BP1^−/−^* cells showed a nonapoptotic-related pannuclear γ-H2AX staining ([Fig. 5 E](#fig5){ref-type="fig"} and [Fig. S5](http://www.jcb.org/cgi/content/full/jcb.201110124/DC1){#supp5}). Pannuclear γ-H2AX staining has been associated with accumulation of ssDNA and activation of the ATR pathway as a consequence of replicative stress or replication fork stalling ([@bib44]). These results suggest that 53BP1 abrogation switches the type of DDR induced by TRF1 deletion.

The fact that *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* newborn mice showed aggravated skin phenotypes compared with the single *TRF1^Δ/Δ^* *K5-Cre* controls prompted us to analyze DDR activation before birth. To this end, we analyzed the levels of γ-H2AX, p53, and p21 in the developing skin of embryonic day 16.5 (E16.5) embryos ([Fig. 6, A--D](#fig6){ref-type="fig"}). *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* embryos showed a fourfold increase in γ-H2AX--positive cells in the developing skin compared with *TRF1^Δ/Δ^ 53BP1^+/+^* embryos ([Fig. 6, A and D](#fig6){ref-type="fig"}). Similarly, p53- and p21-positive cells were elevated more than twofold in *TRF1^Δ/Δ^ K5-Cre 53BP1^−/−^* embryos compared with single-mutant *TRF1^Δ/Δ^ K5-Cre* controls ([Fig. 6, B--D](#fig6){ref-type="fig"}). Together, these results indicate an earlier onset of DNA damage and subsequent DDR activation associated with 53BP1 deficiency, which is in agreement with the more severe skin morphogenesis defects at birth in *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* newborns compared with the *TRF1* single-mutant controls.

![**53BP1 deficiency leads to an earlier DDR onset during embryonic development.** (A--C) Percentage of γ-H2AX (A)--, p53 (B)-, and p21 (C)-positive cells in the back skin of embryos of the indicated genotypes at either day 16.5 postcoitum (E16.5) or in 1-d-old newborns (P1). *n*, number of embryos or mice analyzed. Error bars represent standard error. Statistical differences were calculated using the Student's *t* test, and p-values are indicated. \*, P \< 0.05; \*\*\*, P \< 0.001. (D) Representative images of back skin sections stained for γ-H2AX, p53, and p21 from embryos (E16.5) of the indicated genotypes. Arrowheads mark γ-H2AX--positive cells.](JCB_201110124_Fig6){#fig6}

Based on the stronger CHK1 activation observed in *TRF1^Δ/Δ^ 53BP1^−/−^* as compared with *TRF1^Δ/Δ^ 53BP1^+/+^* MEFs ([Fig. 2](#fig2){ref-type="fig"}), we tested phosphorylated CHK1 (p-CHK1) levels in the epidermis of E16.5 embryos ([Fig. 7, A and B](#fig7){ref-type="fig"}). In the developing epidermis of *TRF1^Δ/Δ^ K5-Cre 53BP1^−/−^* embryos, a threefold increase of p-CHK1--positive cells was readily observed as compared with the levels detected in *TRF1^Δ/Δ^ K5-Cre* embryos. These results are consistent with the higher percentage of p53--p21-positive cells observed in E16.5 *TRF1^Δ/Δ^ K5-Cre 53BP1^−/−^* embryos ([Fig. 6](#fig6){ref-type="fig"}). Interestingly, no p-CHK1--positive cells were detected in newborn skin of any of the aforementioned genotypes under study (unpublished data). It has been reported that massive ATR--CHK1 activation takes places especially during embryonic development when tissues are highly proliferative ([@bib44]).

![**53BP1 deficiency leads to a hyperactivation of the ATR-dependent DDR during embryonic development.** (A) Percentage of p-CHK1--positive cells in the back skin of embryos of the indicated genotypes at day 16.5 postcoitum (E16.5). *n*, number of analyzed embryos. Error bars represent standard error. Statistical differences were calculated using the Student's *t* test, and p-values are indicated. \*\*\*, P \< 0.001. (B) Representative images of back skin sections stained for p-CHK1 (Ser345) from embryos (E16.5) of the indicated genotypes. Arrows mark p-CHK1--positive cells.](JCB_201110124_Fig7){#fig7}

Massive arrest of *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* keratinocytes in G2
---------------------------------------------------------------------

To further confirm aggravation of TRF1-associated cellular phenotypes as a consequence of 53BP1 deletion, we performed flow cytometry analysis of isolated newborn skin keratinocytes to determine cell cycle profile and polyploidy. *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* keratinocytes showed a threefold increase in the percentage of cells with 4n DNA content and a twofold increase in polyploid cells (\>4n) compared with *TRF1^Δ/Δ^* *K5-Cre* keratinocytes ([Fig. 8, A and B](#fig8){ref-type="fig"}). The accumulation of cells with a 4n DNA content might correspond to either cells arrested in G2/M or to polyploid cells arrested in G1. To distinguish between these two possibilities, we analyzed the number as well as the staining pattern of phospho--Histone H3 (Ser10)-positive cells in newborn mice. Mitotic phosphorylation of H3 initiates nonrandomly in pericentromeric heterochromatin in late G2 interphase cells, in which staining is visualized as discrete foci. After initiation, H3 phosphorylation spreads throughout the condensing chromatin, and the staining increases progressively until complete nuclear staining of the mitotic chromatin is achieved ([@bib25]). In contrast to wild-type and *53BP1^−/−^* skin in which \<10% of the cells were p-H3 positive, *TRF1^Δ/Δ^* *K5-Cre* and *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* epidermis showed a three- and fivefold increase in p-H3--positive cells, respectively ([Fig. 8, C and D](#fig8){ref-type="fig"}). The H3 staining pattern between TRF1-proficient and TRF1-deficient cells was also remarkably different. In particular, although p-H3--positive cells in TRF1-proficient skin showed both foci (typical of G2) and pannuclear (typical of mitosis) staining, all p-H3--positive cells from the TRF1-deficient epidermis presented foci and, therefore, corresponded to G2 ([Fig. 8 D](#fig8){ref-type="fig"}). These findings demonstrate that a large proportion of *TRF1*-deleted cells are arrested in G2 and fail to proceed to mitosis and that this defect is exacerbated by 53BP1 deficiency.

![**Keratinocytes doubly deficient for TRF1 and 53BP1 are arrested in G2.** (A) Representative FACS profiles of isolated newborn keratinocytes of the indicated genotypes. The different cell cycle phases are marked between the red dotted lines. The arrows indicate the peaks corresponding to G2--M phase of the cell cycle. (B) Quantification of the percentage of cells at different phases of the cell cycle by FACS analysis of newborn *TRF1^Δ/Δ^ K5-Cre* and *TRF1^Δ/Δ^ K5-Cre 53BP1^−/−^* keratinocytes. Cells were stained with propidium iodide. *n*, number of independent newborn mice used per genotype. (C) Percentage of phospho--Histone 3 (S10)-positive cells in the back skin of mice of the indicated genotypes at birth (P1). *n*, number of mice analyzed. (B and C) Error bars represent standard error. Statistical differences were calculated using the Student's *t* test, and p-values are indicated. (D) Representative images of back skin sections stained for p-H3. Insets represent larger magnifications of the cell within the squares. Black arrows indicate cells in mitosis (intense and whole nuclear staining), and red arrows show cells in G2 (foci staining).](JCB_201110124_Fig8){#fig8}

Longer telomeres in *TRF1^Δ/Δ^ K5-Cre 53BP1^−/−^* mouse epidermis
-----------------------------------------------------------------

To address whether the severe developmental defects of the *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* epidermis were caused by telomere length defects associated with 53BP1 deficiency, we performed telomere quantitative FISH (Q-FISH) directly on skin sections ([Fig. 9, A--C](#fig9){ref-type="fig"}). Centromere fluorescence was also performed to correct for differences in ploidy. Interestingly, the skin of *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* mice showed higher telomere fluorescence than that of *TRF1^Δ/Δ^* *K5-Cre 53BP1^+/+^* controls, both when measuring individual telomere dots and when considering mean telomere fluorescence per nuclei ([Fig. 9, A and B](#fig9){ref-type="fig"}). In particular, *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* skin showed an increased number of telomeres with high fluorescence (\>2,000 arbitrary units of fluorescence) and a decrease in the amount of telomeres showing low fluorescence (\<250 arbitrary units of fluorescence) compared with *TRF1^Δ/Δ^* *K5-Cre 53BP1^+/+^* littermates ([Fig. 9 A](#fig9){ref-type="fig"}). Because 53BP1 deficiency also results in increased telomeric recombination ([Fig. 1, C and D](#fig1){ref-type="fig"}), we speculate that the presence of individual telomere signals showing high fluorescence in *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* skin ([Fig. 9 A](#fig9){ref-type="fig"}) may be the result of increased HR repair at telomeres. Increased total nuclear telomere fluorescence in *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* skin is associated with increased ploidy compared with *TRF1^Δ/Δ^* *K5-Cre 53BP1^+/+^* skin, as indicated by increased centromeric fluorescence in *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* skin compared with both wild-type and *TRF1^Δ/Δ^* *K5-Cre* controls ([Fig. 9 C](#fig9){ref-type="fig"}). Indeed, when mean total nuclear telomere fluorescence was normalized to mean total nuclear centromere fluorescence, no significant differences could be detected between the different genotypes ([Fig. 9 B](#fig9){ref-type="fig"}).

![**Keratinocytes doubly deficient for TRF1 and 53BP1 show increased telomere and centromere fluorescence.** (A) Telomere fluorescence distribution of individual telomere dots in back skin sections of mice of the indicated genotype as determined by Q-FISH analysis. *n*, number of mice used for the analysis. The total number of telomeres analyzed. The mean and median fluorescence as well as standard error values are shown for each genotype. (B) Quantification of total telomere fluorescence per nucleus in back skin sections from mice of the indicated genotypes. Absolute fluorescence values and centromere normalized values are depicted. The number of mice used for the analysis and the total number of nuclei analyzed for each genotype are indicated. Bars represent standard errors. (C) Total centromere fluorescence per nucleus distribution in back skin sections from mice of the indicated genotypes. The number of mice used for the analysis and the total number of nuclei analyzed for each genotype are indicated. Red lines correspond to mean values. (B and C) The Student's *t* test was used for statistical analysis, and p-values are indicated. a.u.f., arbitrary units of fluorescence.](JCB_201110124_Fig9){#fig9}

Discussion
==========

53BP1 is required for the C-NHEJ--mediated ligation of DNA ends ([@bib61]; [@bib34]; [@bib65]; [@bib19]; [@bib37]; [@bib48]). Here, we address the role of 53BP1 at dysfunctional telomeres caused by TRF1 deficiency. In particular, we study the impact of 53BP1 deletion on both the chromosomal defects as well as the severe cellular and organismal phenotypes associated with *TRF1* deletion in vivo. We initially reasoned that 53BP1 deficiency could significantly rescue end to end fusions in *TRF1*-depleted cells by blocking the C-NHEJ at dysfunctional telomeres, and this, in turn, might impact favorably on the survival of *TRF1^Δ/Δ^ K5-Cre* mice. As expected, at the chromosomal level, 53BP1 deficiency in *TRF1*-deleted MEFs led to a significant rescue of chromosome-type end to end fusions but also to an unexpected simultaneous increase in telomeric recombination events, suggesting a switch from C-NHEJ-- to HR-mediated repair. This was accompanied by a hyperactivation of the ATR-dependent DDR as indicated by increased RPA at telomeres and augmented phosphorylation of the ATR downstream checkpoint kinase CHK1. At the organismal level, these molecular events resulted in an aggravation of the skin phenotypes associated with TRF1 deletion, which was associated with an earlier onset of DNA damage and DDR activation during embryonic development, leading to massive G2 arrest in the skin of *TRF1^Δ/Δ^ K5-Cre 53BP1^−/−^* newborn mice. This phenotypic aggravation resulting from combined TRF1 and 53BP1 deficiencies is in contrast to the recently described impact of *53BP1* deletion in rescuing phenotypes associated with BRCA1 deletion. However, in that scenario, the phenotypes observed were attributed to defects in HR ([@bib8]; [@bib6]; [@bib7]).

In summary, our data support a model in which deletion of 53BP1 in TRF1-deficient cells impairs the C-NHEJ repair pathway, decreasing the occurrence of chromosome-type end to end telomere fusions while inducing a persistent DNA damage signal that activates the ATR-dependent DDR and the HR repair pathway ([Fig. 10](#fig10){ref-type="fig"}). In particular, in the absence of 53BP1, dysfunctional telomeres accumulate higher levels of ssDNA and RPA indicative of increased resection ([Fig. 3](#fig3){ref-type="fig"} and [Fig. 4](#fig4){ref-type="fig"}). This, in turn, triggers a hyperactivation of the ATR--CHK1 pathway that further amplifies DDR signaling ([Fig. 2 D](#fig2){ref-type="fig"} and [Fig. 7](#fig7){ref-type="fig"}) and that may lead to the G2 arrest observed in vivo in *TRF1^Δ/Δ^ K5-Cre 53BP1^−/−^* mice ([Fig. 8](#fig8){ref-type="fig"}). Finally, resected telomeres may be recognized as substrates by the HR machinery, which may explain the increased frequency of telomeric sister chromatid exchange triggered by 53BP1 abrogation in *TRF1*-deficient cells ([Fig. 1](#fig1){ref-type="fig"}). Our results are in agreement with the model proposed by [@bib7] in which removal of 53BP1 from the DSB is crucial for the ATM-dependent resection to produce HR-competent ssDNA. 53BP1 binding to dysfunctional TRF1-null telomeres might function by blocking telomere resection, thereby interfering with HR. Processing of exposed telomeres by HR-dependent repair generates interchromosomal recombination events that lead to elongation of telomeric tracts, a mechanism known as alternative lengthening of telomeres ([@bib20]; [@bib60]). In support of this notion, 53BP1 loss also leads to a higher proportion of long telomeres in TRF1-deficient keratinocytes ([Fig. 9](#fig9){ref-type="fig"}). Unexpectedly, neither the decreased frequency of end to end fusions nor the activation of the HR repair pathway at uncapped telomeres upon 53BP1 loss alleviated the deleterious effects of TRF1 deficiency in vivo; instead, they were aggravated. These observations suggest that fusion of dysfunctional telomeres may represent a mechanism to temporally heal dysfunctional telomeres and, in this manner, reduce DDR signaling. These results also suggest that severe phenotypes present in the skin of *TRF1^Δ/Δ^ k5-Cre* mice are not solely caused by chromosome fusions but rather by increased DNA damage signaling at telomeres ([@bib37]; [@bib52]). Although an activated HR could be expected to rescue fork stalling at telomeres, the fact that neither the incidence of MTS nor a rescue in lethality was detected upon 53BP1 abrogation supports a model in which TRF1 has a more specific function in telomere replication. In fact, TRF1 has been proposed to facilitate telomeric DNA replication by recruiting/activating the BLM and RTEL helicases involved in the removal of G4 DNA structures formed in single-stranded TTAGG repeats ([@bib52]).

![**Model used in this study.** TRF1 loss yields dysfunctional/uncapped telomeres that are marked with γ-H2AX foci. Dysfunctional telomeres elicit a DNA damage response (DDR) by activation of upstream kinases, DNA protein kinase, ATM, and ataxia telangiectasia and Rad3 related (ATR) that leads to a p53--p21-mediated cell cycle arrest until the damage is repaired. Activation of either the classical or alternative nonhomologous end-joining (C-NHEJ or A-NHEJ, respectively) repair pathways results in end to end fusions. The joining of dysfunctional telomeres results in the abolishment of the DNA damage signal by reducing the number of exposed chromosome ends and, thereby, can be considered as a temporal healing of the damage at least until the following mitosis, in which fused chromosomes will lead to further DSBs. In 53BP1-deficient cells with an impaired C-NHEJ pathway, the DNA damage signal associated with dysfunctional telomeres persists. Absence of 53BP1 at dysfunctional telomeres facilitates resection of telomeric DNA that gets coated by RPA enhancing ATR--CHK1 activation that further amplifies the DDR signaling, leading to an accelerated G2 arrest and eventual cell death. Moreover, resected telomeres act as substrates for the HR machinery, resulting in a higher incidence of inter- and intrachromosomal telomeric recombination events that impact telomere length changes. As a consequence, mice doubly deficient for TRF1 and 53BP1 in skin accumulate telomeric DNA damage more rapidly than TRF1 single knockout, severely blocking skin morphogenesis early during embryonic development.](JCB_201110124_Fig10){#fig10}

The aggravation of phenotypes associated with TRF1 depletion by 53BP1 deficiency is a consequence of an increased ATR signaling caused by either aberrant processing of dysfunctional telomeres and/or by an increased number of exposed chromosome ends as a result of reduced end to end fusion frequency. Previous studies have suggested that proteins of the NHEJ pathway can have suppressive effects on HR ([@bib47]; [@bib69]). More specifically, the frequency of HR is enhanced in the absence of the NHEJ proteins Ku70, XRCC4, and DNA-PKcs ([@bib47]) as well as by overexpression of a dominant-negative 53BP1 fragment ([@bib69]). However, rescue of genomic instability in *BRCA1^−/−^* cells is solely achieved by loss of 53BP1 and not by the loss of any other component of the NHEJ pathway ([@bib7]). At telomeres, the Ku70--Ku80 complex has also been shown to repress exchange between sister telomeres upon TRF2 loss ([@bib10]). In accordance with our findings, loss of 53BP1 in *TRF2*-deleted cells also led to an increase in T-SCE ([@bib48]). However, to our knowledge, the in vivo effects of either Ku70 or 53BP1 abrogation in combination with a deficiency in a shelterin component has not been reported until now. A similar synthetic genetic interaction has been previously described for *DNA-PKcs* deficiency in late generation *Terc^−/−^*-deficient mice presenting very short telomeres ([@bib38]; [@bib67]). Thus, the *G4-Terc^−/−^* mice in combination with *DNA-PKc* deletion experienced an accelerated loss of organismal viability and reduction in median lifespan ([@bib22]; [@bib67]). Future work in which lack of a shelterin component is combined with a deficiency in any other component of the classical NHEJ, such as Ku80 and Lig4, will provide insights on whether the observed in vivo phenotypes are solely caused by the persistence of exposed chromosome ends or, on the contrary, is specific of 53BP1 deficiency.

Finally, it has recently been reported that p53 not only regulates cell cycle arrest at the G1/S in response to telomere dysfunction but also at the G2/M transition ([@bib28]; [@bib58]). Telomere uncapping caused by *TRF1* deletion delays mitotic entry in a p53--p21-dependent manner ([@bib37]; [@bib58]). Our results strongly reinforce this notion. The earlier onset of telomeric damage during embryonic development in *TRF1^Δ/Δ^ K5-Cre 53BP1^−/−^* compared with *TRF1^Δ/Δ^ K5-Cre 53BP1^+/+^* triggers a G2 cell cycle arrest severely impairing morphological development of the skin. Our work provides the first evidence of deleterious genetic interaction between a shelterin component and a DNA damage repair component, TRF1 and 53BP1, respectively.

Materials and methods
=====================

Generation of conditional double TRF1/53BP1 knockout mice
---------------------------------------------------------

To generate *TRF1^Δ/Δ^ K5-Cre 53BP1^−/−^* mice, *TRF1^+/Δ^ K5-Cre 53BP1^+/+^* mice ([@bib37]) were first crossed with *TRF1^+/+^ 53BP1^−/−^* mice ([@bib64]). The crosses between double-heterozygote *TRF1^+/flox^ 53BP1^+/−^* and *TRF1^+/Δ^ K5-Cre 53BP1^+/−^* mice generated double-homozygote *TRF1^Δ/Δ^ K5-Cre 53BP1^−/−^* mice. Both parental mouse strains used to generate the *TRF1^Δ/Δ^ K5-Cre 53BP1^−/−^* mouse model have a C57BL/6 genetic background. All mice were generated and maintained at the Spanish National Cancer Centre under specific pathogen-free conditions in accordance with the recommendation of the Federation of European Laboratory Animal Science Associations.

Immunoblotting
--------------

Whole-cell extracts from LT-Cre--infected MEFs were prepared by resuspending the cells in lysis buffer (50 mM Tris, pH 7.5, 200 mM NaCl, 0.2% NP-40, 0.5% Tween, and 50 mM glycerophosphate) containing PMSF and protease inhibitors. 50 µg of total protein was analyzed by gel electrophoresis followed by Western blotting. The blocking reagent (PhosphoBLOCKER; Cell Biolabs, Inc.) was used to block the membranes. The following antibodies were used for immunoblotting: anti-TRF1 mouse monoclonal antibody (Abcam), antiphospho-KAP1 (S824) rabbit polyclonal, antiphospho-KAP1 (S473) rabbit polyclonal (BioLegend), antiphospho--anti-CHK2 mouse monoclonal (Millipore), antiphospho-CHK1 (Ser345) rabbit polyclonal (Cell Signaling Technology), anti-CHK1 mouse monoclonal (Novocastra), antiphospho-RPA32 (S4/S8) rabbit polyclonal (Bethyl Laboratories, Inc.), anti-RPA32 rat monoclonal (Cell Signaling Technology), and anti-RAD21 rabbit polyclonal (gift from A. Losada, Spanish National Cancer Centre, Madrid, Spain). Antibody binding was detected after incubation with a secondary antibody coupled to horseradish peroxidase using enhanced chemiluminescence.

Retroviral infections
---------------------

Retroviral infections were performed as previously described ([@bib37]). The excision of *TRF1* exon I by Cre-mediated recombination was confirmed by PCR analysis using primers forward E1 popout, 5′-ATAGTGATCAAAATGTGGTCCTGGG-3′, and reverse SA1, 5′-GCTTGCCAAATTGGGTTGG-3′. Amplification of the wild-type, flox, and knockout alleles renders 1.4-, 1.5-, and 0.48-kb fragments, respectively.

Immunofluorescence staining techniques
--------------------------------------

Cre-infected MEFs were treated for 5 min with Triton X-100 buffer ([@bib43]) for nuclear extraction, fixed 10 min in 4% buffered formaldehyde, permeabilized with 0.1% PBS--Triton X-100 for 10 min, and blocked with 2% fetal bovine serum in PBS for 1 h. Sections were incubated overnight at 4°C with the primary antibody at a 1:200 dilution. TIF were detected using a rabbit polyclonal to RAP1 (Bethyl Laboratories, Inc.) and a mouse monoclonal antibody raised against phospho--Histone 2 H2AX-Ser139 (Millipore) and further incubated with Cy3 goat anti--rabbit and 488 Alexa Fluor goat anti--mouse antibody (1:400; Jackson ImmunoResearch Laboratories, Inc.). Telomeric RPA foci were detected using a rabbit polyclonal to RAP1 (Bethyl Laboratories, Inc.) and a rat polyclonal antibody raised against RPA32 (4E4; Cell Signaling Technology) and further incubated with Cy3 goat anti--rabbit, 488 Alexa Fluor goat anti--rat, and 488 Alexa Fluor goat anti--mouse antibody (1:400; Jackson ImmunoResearch Laboratories, Inc.). For ssDNA immunofluorescence, cells were grown with 10 µM BrdU for 48 h and then treated with either 0 or 30 Gy of ionizing radiation and left for 90 min at 37°C. Cells were fixed with ice-cold methanol for 1 h at −20°C. BrdU was detected using a FITC-conjugated mouse monoclonal anti-BrdU (RPN20AB; GE Healthcare). Slides were mounted in Vectashield (Vector Laboratories) with DAPI. Confocal microscopy was performed at room temperature with a laser-scanning microscope (TCS SP5; Leica) using a Plan Apochromat 63× NA oil immersion objective (HCX; Leica). The pictures show the maximal projection of z stacks generated using advance fluorescence software (LAS; Leica).

Measurement of sister telomere recombination events using CO-FISH
-----------------------------------------------------------------

Exponentially growing primary MEFs were subcultured in the presence of BrdU (Sigma-Aldrich) at a final concentration of 10^−5^ M and then allowed to replicate their DNA once at 37°C for 24 h. Colcemid was added at a concentration of 0.1 µg/ml during the last 4 h. Cells were then recovered, subjected to hypotonic shock, and fixed in methanol/acetic acid (3:1) as previously described ([@bib50]). CO-FISH was performed as previously described ([@bib2]) using first a telomeric (CCCTAA)~7~ peptide nucleic acid (PNA) probe labeled with Cy3 and then a second telomeric (TTAGGG)~7~ PNA probe labeled with Alexa Fluor 488. Metaphase spreads were captured on a fluorescence microscope (DMRB; Leica). For analysis of chromosomal aberrations, metaphases were analyzed by superimposing the telomere image on the DAPI image using the TFL-Telo software (provided by P. Lansdorp, British Columbia Cancer Research Center, Vancouver, British Columbia, Canada).

TRF and G-strand overhang analyses
----------------------------------

One million Cre-infected LT-immortalized MEFs were included in agarose plugs, and TRF analysis was performed as previously described ([@bib50]). After overnight digestion in LDS buffer (10 mM Tris, pH 8, 100 mM EDTA, and 1% lithium dodecyl sulphate), the plugs were digested with 0 or 100 U of mung bean nuclease. Then, the plugs were digested with MboI overnight and run on pulse-field electrophoresis gels. Then, sequential in-gel hybridizations in native and denaturing conditions were performed. Values of the G-strand overhang signals were corrected by the telomere signal in denaturing gel conditions.

Histopathological analyses and immunohistochemistry staining techniques
-----------------------------------------------------------------------

Skin samples and other mouse tissues were fixed in 10% buffered formalin, dehydrated, and embedded in paraffin. For histopathological analysis, 4-µm sections were deparaffinized and stained with hematoxylin and eosin according to standard procedures.

Immunohistochemistry was performed on deparaffinized skin sections processed with 10 mM sodium citrate, pH 6.5, and cooked under pressure for 2 min. Slides were washed in water and then in buffer TBS with 0.5% Tween 20, blocked with peroxidase, washed with TBS with 0.5% Tween 20 again, and blocked with fetal bovine serum followed by another wash. The slides were incubated with the following primary antibodies: rabbit polyclonal to p53 (CM5; Novocastra), goat polyclonal to p21 (C-19-G; Santa Cruz Biotechnology, Inc.), mouse monoclonal to phospho--Histone H2AX (Ser139), rabbit monoclonal to p-CHK1 (Ser345), rabbit polyclonal to SOX9 (Millipore), mouse monoclonal to p63 (p63-4A4; NeoMarkers), rabbit polyclonal to cytokeratin 14 (AF64; Covance), rabbit polyclonal to cytokeratin 10 (Covance), rabbit polyclonal to caspase 3 active (R&D Systems), and rabbit polyclonal to phospho--Histone 3 H3 (Ser10; Millipore). Slides were then incubated with secondary antibodies conjugated with peroxidase obtained from Dako. For signal development, DAB (Dako) was used as a substrate. Sections were lightly counterstained with hematoxylin and analyzed by light microscopy.

The pathologies observed were classified as severe or moderate. The severe pattern is characterized as a high-grade dysplasia in the skin, tongue, palate, esophagus, nonglandular stomach, nails, and urinary bladder, with marked cytological atypia with disturbed polarity of cells, irregular epithelia stratification, loss of nuclear polarity, prominent nucleoli, and nuclear polymorphism. All tissues present focal hyperplasia and hyperkeratosis. The back skin shows epithelial necrosis and complete absence of hair follicles. Moderate pattern is characterized by a lower grade of dysplasia in skin, tongue, nonglandular stomach, and esophagus, with cells larger than normal, often with irregular stratification, enlarged nuclei, and in some cases, loss of nuclear polarity. The back skin shows that primordial hair follicles and the nails are unaffected.

Flow cytometric analysis (FACS)
-------------------------------

Primary keratinocyte from newborn mice (P1) were obtained after floating the skin overnight with dermis side down on trypsin without EDTA at 4°C to separate the epidermis from the dermis previously described ([@bib42]). The epidermis was then minced with a razor blade, resuspended in culture medium (CnT-02; CELLnTEC) supplemented with 0.2 mM CaCl, and stirred for 30 min at room temperature. Cell suspension was filtered through a 70-µm mesh nylon gauze, and keratinocytes were washed twice with PBS and fixed/permeabilized with ice-cold 70% ethanol. Fixed cells were washed with PBS and resuspended in 1 ml PBS containing 0.2 µg propidium iodide and 100 µg RNase. The samples were incubated for 30 min at 37°C, and the FACS analysis was performed in a flow cytometry system (FACSCanto II; BD). The data were analyzed with the software FACSDiva v5.1.1 (BD).

Telomere and centromere fluorescence analyses on skin sections
--------------------------------------------------------------

Telomere and centromere Q-FISH directly on skin sections was performed as previously described ([@bib37]) using a telomeric (CCCTAA)~7~ and a centromeric major satellite (GGGTTA)~7~ PNA probes labeled with Cy3, respectively. The images were capture at room temperature using a charge-coupled device camera (FK512; Cohu Electronics) on a fluorescence microscope (DMRB) with a Plan Apochromat 100× 1.40 NA oil immersion objective (HCX) using Q-FISH software (Leica) in a linear acquisition mode to prevent the saturation of fluorescence intensity. The TFL-Telo program was used to quantify the telomere fluorescence intensity of individual telomeres.

Online supplemental material
----------------------------

Fig. S1 shows the cell cycle profile of Cre-infected LT-immortalized MEFs. Fig. S2 shows normal telomere length and G-strand overhangs in *TRF1^Δ/Δ^ 53BP1*^−/−^ LT-immortalized MEFs. Fig. S3 shows that 53BP1 deficiency in *TRF1^Δ/Δ^*-immortalized MEFs leads to increased levels of phosphorylated CHK1 and phosphorylated RPA. Fig. S4 shows histopathological findings in different stratified epithelia of *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* mice at birth. Fig. S5 shows that no apoptotic cells are detected in *TRF1^Δ/Δ^* *K5-Cre 53BP1^−/−^* neonate skin. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201110124/DC1>.
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